These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 2566316)

  • 1. Psychotropic medication of mentally retarded residents in community long-term care facilities.
    Buck JA; Sprague RL
    Am J Ment Retard; 1989 May; 93(6):618-23. PubMed ID: 2566316
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A national study of prescribed drugs in institutions and community residential facilities for mentally retarded people.
    Hill BK; Balow EA; Bruininks RH
    Psychopharmacol Bull; 1985; 21(2):279-84. PubMed ID: 4001292
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Psychoactive drug use in public and community residential facilities for mentally retarded persons.
    Intagliata J; Rinck C
    Psychopharmacol Bull; 1985; 21(2):268-78. PubMed ID: 4001291
    [No Abstract]   [Full Text] [Related]  

  • 4. A survey of psychotropic medication in mental retardation facilities.
    Tu JB
    J Clin Psychiatry; 1979 Mar; 40(3):125-8. PubMed ID: 33967
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Psychotropic use in community residential care facilities: A prospective cohort study.
    Lakey SL; Gray SL; Sales AE; Sullivan J; Hedrick SC
    Am J Geriatr Pharmacother; 2006 Sep; 4(3):227-35. PubMed ID: 17062323
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Treatment with psychotropic drugs in various facilities for mentally handicapped patients].
    Meins W; Auwetter J; Krausz M; Turnier Y
    Nervenarzt; 1993 Jul; 64(7):451-5. PubMed ID: 8103571
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes in psychotropic drug use in long-term residents of an ICF/MR facility.
    Hancock RD; Weber SL; Kaza R; Her KS
    Am J Ment Retard; 1991 Sep; 96(2):137-41. PubMed ID: 1681829
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Use of psychotropic medication among individuals with mental retardation].
    Baasland G; Engedal K
    Tidsskr Nor Laegeforen; 2009 Sep; 129(17):1751-3. PubMed ID: 19756056
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [How should mentally handicapped adults with depressive disorders be treated psychopharmacologically?].
    Meins W
    Nervenarzt; 1996 Mar; 67(3):216-8. PubMed ID: 8901279
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monitoring and evaluating psychotropic drug use for persons with mental retardation: a follow-up report.
    Briggs R
    Am J Ment Retard; 1989 May; 93(6):633-9. PubMed ID: 2719846
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Psychotropic medication patterns among youth in foster care.
    Zito JM; Safer DJ; Sai D; Gardner JF; Thomas D; Coombes P; Dubowski M; Mendez-Lewis M
    Pediatrics; 2008 Jan; 121(1):e157-63. PubMed ID: 18166534
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Some studies in an institution for the mentally retarded.
    Sewell J; Werry JS
    N Z Med J; 1976 Oct; 84(574):317-9. PubMed ID: 14320
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Issues in psychopharmacology with the mentally retarded.
    Mouchka S
    Psychopharmacol Bull; 1985; 21(2):262-7. PubMed ID: 4001290
    [No Abstract]   [Full Text] [Related]  

  • 14. Impact of interdisciplinary team review on psychotropic drug use with persons who have mental retardation.
    Findholt NE; Emmett CG
    Ment Retard; 1990 Feb; 28(1):41-6. PubMed ID: 2308511
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of psychotropic medication in Oklahoma: a statewide survey.
    Spreat S; Conroy JW; Jones JC
    Am J Ment Retard; 1997 Jul; 102(1):80-5. PubMed ID: 9241410
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Psychotropic medicines to patients with mental retardation].
    Bygdnes AM; Kristiansen A
    Tidsskr Nor Laegeforen; 2007 Apr; 127(8):1028-30. PubMed ID: 17457386
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Individuals with mental retardation in residential facilities: findings from the 1987 National Medical Expenditure Survey.
    Cunningham PJ; Mueller CD
    Am J Ment Retard; 1991 Sep; 96(2):109-17. PubMed ID: 1930944
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A clinical pharmacy service to reduce psychotropic medication use in an institution for mentally handicapped persons.
    Inoue F
    Ment Retard; 1982 Apr; 20(2):70-4. PubMed ID: 7078402
    [No Abstract]   [Full Text] [Related]  

  • 19. Prevalence of psychotropic drug use in nursing homes for the aged in Quebec and in the French-speaking area of Switzerland.
    Gobert M; D'hoore W
    Int J Geriatr Psychiatry; 2005 Aug; 20(8):712-21. PubMed ID: 16035123
    [TBL] [Abstract][Full Text] [Related]  

  • 20. National survey of community residential facilities: a profile of facilities and residents in 1977.
    Bruininks RH; Hauber FA; Kudla MJ
    Am J Ment Defic; 1980 Mar; 84(5):470-8. PubMed ID: 7361824
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.